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INTRODUCTION
Adenocarcinoma in situ (AIS) of the uterine cervix is thought 
to be the precursor of invasive adenocarcinoma. Many studies 
have shown that the incidence of AIS and cervical cancer has 
been increasing in women under the age of 35 years [1,2]. The 
increasing incidence of human papillomavirus 18 infection 
and increasing oral contraceptive uses are considered to be 
the main causes of this increasing incidence of AIS of the 
uterine cervix [3]. 
AIS of the uterine cervix presents a major clinical difficulty 
with regard to early detection by routine cytology or endo­
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Objective: To evaluate the occurrence of residual or recurrent disease after conization for adenocarcinoma in situ (AIS) of the 
uterine cervix.
Methods: Medical records of 99 patients with a histologically diagnosis of AIS of the uterine cervix by conization between 1991 
and 2008 were reviewed retrospectively.
Results: Seventy eight of 99 patients (78.8%) had negative and 18 (18.2%) had positive resection margins of the conization 
specimen, and 3 (3.0%) had unknown margin status. Of the 78 patients with negative margins, 45 underwent subsequent 
hysterectomy and residual AIS were present in 4.4% (2/45) of patients. Ten of the 18 patients with positive margins received 
subsequent hysterectomy and 3 patients (30%) had residual AIS. Twenty­eight patients had conservative treatment and during 
the median follow­up time of 23.5 months (range, 7 to 124 months), only one patient (3.6%) had recurrent AIS and was treated 
with a simple hysterectomy. Eight patients became pregnant after conization, 4 of them delivered healthy babies, one had a 
spontaneous abortion and 3 were ongoing pregnancies.
Conclusion: Patients with positive resection margins after conization for AIS of the uterine cervix are significantly more likely 
to have residual disease. However, negative resection margin carries a lower risk for residual AIS, therefore conservative 
management with careful surveillance seems to be feasible in women who wish to preserve their fertility.
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cervical curettage (ECC), because it is multifocal and often 
found in the upper cervical canal, so that it may be missed 
during colposcopic examination [4,5]. Therefore, hysterectomy 
is considered as the standard treatment for AIS of the uterine 
cervix. However, controversy still remains because it often 
occurs in young aged patients who desire to preserve their 
fertility, and recent studies suggest that the majority of AIS 
of the uterine cervix is located around the squamocolumnar 
junction and most are unifocal [6,7]. 
Recently, conservative treatment with conization has been 
introduced as a treatment modality for AIS of the uterine 
cervix for patients who desire fertility preservation [6,8]. 
However, the risk of whether residual or recurrent disease 
exists after conization remains uncertain [9­12]. Even though 
negative resection margins after conization are considered as 
adequate management, there are reported risks of residual 
or recurrent diseases [12­15]. Therefore, long term follow­up 
after conization is suggested, although it is difficult to follow­
up sufficiently after conization due to limited colposcopic 
findings and an increased incidence of cervical stenosis.
The aims of this study were to analyze the resection margin 
status on conization specimens to estimate residual or 
recurrent disease after conization, and to evaluate the safety 
of conization for the treatment of AIS of the uterine cervix.
MATERIALS AND METHODS
We retrospectively analyzed the medical records of patients 
with AIS of the uterine cervix who were diagnosed by 
conization at Cheil General Hospital and Women’s Healthcare 
Center from January 1991 to December 2008. Ethical approval 
for reviewing the medical records of the patients was 
obtained from the Cheil General Hospital Ethics Committee, 
Korea.
Standard techniques of cold knife conization were utilized, 
and the depth and width of the conization was decided 
individually by the operating surgeon’s experience based 
on the pictures of colposcopy. Then, additional endocervical 
margin resection was done with a right triangle­shaped 
electrode, and the bleeding site was cauterized with a 
round tip electrode. Sturmdorf suture was not used for 
bleeding control of the cold knife conization. Standard large 
loop excision of the transformation zone techniques were 
employed including at least one separate endocervical 
specimen obtained using the 1.0x1.0­cm loop. 
The resection margin status, pathologic results of 
subsequent surgical specimens, and the results of the HPV 
test with Hybrid Capture II (Digene Co., Gaithersburg, MD, 
USA) or the MyHPV chip test (MyGene Co., Seoul, Korea) were 
thoroughly re­evaluated by two experienced pathologists. 
When AIS involvement was noted at the boundary of 
cervical conization specimen, it was categorized as a positive 
resection margin, and when the involvement was within the 
cervical conization specimen, it was categorized as a negative 
resection margin. If the margin status was unclear because the 
data was not available or it was not documented in the report, 
the case was categorized as an unknown resection margin.
Subsequent surgical treatment after initial conization 
consisted of re­conization, simple hysterectomy, modified 
radical hysterectomy, and no further treatment after 
conization. Subsequent hysterectomy was carried out within 
three months of conization, and if it was not, it was considered 
as no further treatment after conization. 
The pathologic results of subsequent surgical specimens 
were evaluated for comparison of residual AIS according 
to the resection margin status after conization. There was 
no patient who was subsequently diagnosed as invasive or 
microinvasive adenocarcinoma in the hysterectomy specimen 
after conization for AIS. A p­value of less than 0.05 was 
statistically significant by using Fisher’s exact test. The follow­
up period was defined as the time from the date of initial AIS 
diagnosis by conization to the last date of follow­up. 
RESULTS
The median age of 99 patients who were treated by 
conization for AIS of the uterine cervix was 40 years (range, 
23 to 66 years), and 32.3% were under the age of 35 years. 
The study population had a median gravidity of three and 
the median parity was two, and 16 (16.2%) were nulliparous. 
The result of the Papanicolaou (PAP) smear showed that one 
patient with a negative intraepithelial lesion, while 60 were 
squamous cell abnormalities including atypical squamous cells 
of undetermined significance, atypical squamous cells cannot 
exclude high­grade lesion, low­grade squamous intraepithelial 
lesion, high­grade squamous intraepithelial lesion, squamous 
cell carcinoma in situ and squamous cell carcinoma. Twenty 
eight patients showed glandular cell abnormalities including 
atypical glandular cells of undetermined significance, atypical 
endocervical cells, AIS, and adenocarcinoma. The remaining 
patients were referred after the biopsy procedure, and the 
initial PAP finding was not obtained. The median follow­up 
period was 31 months (range, 1 to 182 months), and most 
patients (90.9%) underwent cold knife conization rather than 
loop electrosurgical excision procedure (LEEP) for the initial 
diagnostic and therapeutic procedure (Table 1).Safety of conization for adenocarcinoma in situ
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Pathologic findings of the conization specimens showed 
that many AIS cases were accompanied by other pathologic 
findings such as cervical dysplasia, squamous cell carcinoma 
in situ, adenosquamous carcinoma in situ, microinvasive 
squamous cell carcinoma, and microinvasive adenosquamous 
carcinoma of the uterine cervix. The most common pathologic 
finding of the conization specimen was AIS coexisting with 
squamous cell carcinoma in situ (42.4%), and the second most 
common was AIS only (30.3%) (Table 2). 
Eighteen of 99 patients (18.2%) showed positive resection 
margins and 78 (78.8%) showed negative margins. Three 
patients (3.0%) had unknown margin status because they had 
underwent cervical conization at another hospital and there 
was no mention about the margin status on the pathologic 
reports, and they all underwent hysterectomy. Seven of 32 
(21.9%) young aged patients under 35 years showed positive 
resection margins, and 11 of 67 (16.4%) older patients over 
35 years had positive resection margins, and there was no 
statistical difference (p=0.162). Four of 18 patients with 
positive resection margins for AIS and 23 of 78 patients with 
negative resection margins did not receive any additional 
treatment. One patient with a positive resection margin for 
AIS underwent repeated cervical conization 3 months after 
the initial conization (Table 3).
Table 4 shows the relation between the margin status of 
the conization specimens and the pathologic results of the 
hysterectomy specimens. After hysterectomy, 3 (30%) of 10 
patients with positive resection margins for AIS had residual 
AIS, and 2 (4.4%) of 45 patients with negative resection 
margins had residual AIS. The difference in the incidence 
of residual AIS between patients with positive resection 
margins after conization and those with negative margins was 
statistically significant (p=0.037). Three patients with unknown 
resection margin status showed no residual AIS. 
Twenty­eight patients were treated with cervical conization 
only, including one case of repeated cervical conization. The 
median follow­up period was 23.5 months (range, 7 to 124 
months) and median age was 32.5 years (range, 23 to 55 
years). Eight of 28 patients became pregnant after cervical 
conization, 4 resulted in successful full term deliveries, and 3 of 
them were currently pregnant. One patient had spontaneous 
abortion at 7th weeks of gestational age. Only one patient 
(3.6%) had recurrent AIS 47 months after the conization (Table 
5).
The HPV testing was performed in 57 patients, and the 
results showed that the HPV type distribution of HPV 16 
Table 1. Characteristics of the study population (n=99) 
Variables  
Age (yr)    40 (23-66)
    Age ≤ 35 32 (32.3)
Gravidity    3 (0-11)
Parity 2 (0-7)
    N=0 16 (16.2)
    N=1 15 (15.1)
    N=2 48 (48.5)
    N≥3 20 (20.2)
Follow-up duration (mo)    31 (1-182)
Procedure
    Loop electrosurgical excision procedure  9 (9.1)
    Cold knife conization 90 (90.9)
Values are presented as number (%) or median (range).
Table 2. Pathologic findings of the conization specimens
Pathologic findings No. (%)
AIS only 30 (30.3)
AIS+squamous dysplasia 12 (12.1)
AIS+CIS  42 (42.5)
AIS+in situ adenosquamous carcinoma 3 (3.0)
AIS+microinvasive squamous cell carcinoma 11 (11.1)
AIS+microinvasive adenosquamous carcinoma 1 (1.0)
AIS: adenocarcinoma in situ of the uterine cervix, CIS: squamous cell 
carcinoma in situ of the uterine cervix.
Table 3. Margin status of the cervical conization and subsequent 
treatment
Conization margin status
(-) for AIS (+) for AIS Unknown
No further treatment 23   4 0
Re-conization   0   1 0
Simple hysterectomy 38 10 3
Modified radical hysterectomy   7   0 0
Follow-up loss 10   3 0
Total (%) 78 (78.8) 18 (18.2) 3 (3.0)
AIS, adenocarcinoma in situ of the uterine cervix.
Table 4. Margin status of the cervical conization and the pathologic 
result of subsequent specimen 
Conization margin status
(-) for AIS (+) for AIS Unknown
No residual tumor 43 7 3
Residual AIS   2 3 0
% of residual AIS     4.4   30.0  0 
AIS, adenocarcinoma in situ of the uterine cervix.Mi-La Kim, et al.
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was 43.9% (25 patients), and that of HPV 18 was 22.8% (13 
patients). Six patients (10.5%) showed other high risk types of 
HPV such as 31, 35, 45, 52, 56, 58, and 14 patients (24.6%) were 
not infected by HPV. 
DISCUSSION
The AIS of the uterine cervix is a distinct histopathologic 
entity and many clinicians are struggling for the proper 
management. Recently, with the increase in conservative 
treatment, conization of the uterine cervix is gathering 
strength [3,6,7], Therefore, for adequate and secure 
management of patients with AIS, our study aimed at 
evaluating the safety of conization for the treatment of AIS 
of the uterine cervix, and recurrence rates according to the 
resection margin status of conization. Our study suggests that 
patients with negative resection margins after conization for 
cervical AIS, especially who wish to preserve their fertility, may 
be followed carefully with long­term surveillance and warning 
regarding the risks of residual or recurrent disease without 
hysterectomy. Patients with positive resection margins are 
more likely to have residual disease, therefore hysterectomy 
or a second conization may be required for these patients. 
In our study, patients with positive resection margins had 
nearly nine times more residual disease than those with 
Table 5. Follow-up results of conservatively treated patients (including repeated conization)
Case 
no.
Age G P Conization pathology Margin status 
of AIS
Follow-up 
(mo)
Recurrence Remark
1 23 0 0 AIS+CIS Free 26 No
2 37 3 2 AIS+CIS Free 22 No
3 32 1 1 AIS+CIS Free 10 No
4 30 1 0 AIS AIS (+) 27 No Full term delivery
5 55 6 4 AIS Free 15 No
6 28 1 0 AIS+CIS Free 38 No Full term delivery
7 24 1 0 AIS+CIS AIS (+) 27 No Current pregnant status
8 31 1 0 AIS Free 18 No Current pregnant status
9 32 1 1 AIS AIS (+) 12 No
10 45 3 2 AIS Free 21 No
11 42 2 1 AIS+CIS Free 21 No
12 32 1 0 AIS+micro-invasive SCC Free 19 No SAx1
13 39 6 3 AIS+CIS Free 30 No
14 38 5 2 AIS Free 23 No
15 38 2 0 AIS AIS (+) 14 No Repeated conization
16 25 0 0 AIS AIS (+) 31 No Full term delivery
17 30 1 0 AIS+CIS Free   7 No
18 32 1 0 AIS+CIS Free 24 No Full term delivery
19 36 3 2 AIS+CIS Free 18 No
20 25 0 0 AIS Free 124 No
21 35 2 2 AIS Free 74 No
22 32 1 1 AIS Free 50 No
23 33 0 0 AIS+CIS Free 88 No
24 34 3 2 AIS+squamous dysplasia Free 73 Yes Recurred after 47 mo of 
conization
25 43 2 2 AIS Free   9 No
26 55 5 3 AIS Free 27 No Current pregnant status
27 29 0 0 AIS+CIS Free 29 No
28 34 2 1 AIS+CIS Free 21 No
G: gravidity, P: parity, AIS: adenocarcinoma in situ of the uterine cervix, CIS: squamous cell carcinoma in situ of the uterine cervix, SA: 
spontaneous abortion, SCC: squamous cell carcinoma.Safety of conization for adenocarcinoma in situ
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negative margins (30.0% vs. 4.4%). Previous studies reported 
that the incidence of residual disease in patients with negative 
margins after conization for AIS of the uterine cervix is low 
but not negligible [6,7,13,14]. Although the achievement 
of negative margins after conization has been described as 
an adequate treatment, the rates of recurrence and residual 
disease have been reported in up to 50% of cases [12­15]. 
However, recent findings suggest that AIS of the uterine cervix 
is located around the squamo­columnar junction and most 
tumors are unifocal, so that conservative management may 
be safe [6,7]. Our study is consistent with these recent findings 
and showed low residual disease in cases with negative 
resection margins after conization.
 In the present study, of the 27 patients with no further 
treatment after conization and one repeated conization, only 
one patient had a recurrence after conization (3.6%). Our 
study suggest that recurrence and incidence of multifocal 
distribution of AIS is relatively low, however, the possibility of 
multifocal lesions are still not negligible.
The need for conservative management, especially for 
young patients with AIS who desire to preserve their 
fertility, is increasing because the incidence of AIS of the 
uterine cervix is increasing, especially in young women 
and conization as fertility­preserving treatment would be 
an attractive procedure for these patients [3]. In our study, 
32 of 99 patients (32.3%) were under the age of 35, and 16 
patients (16.2%) were nulliparous. Seven of 28 patients (25%) 
who were treated conservatively with conization achieved 
successful full term delivery or ongoing pregnancy. These 
results suggest that young patients with cervical AIS who 
wish to preserve their fertility may be treated effectively with 
conservative conization. However, conservative treatment 
of the patients with cervical AIS needs careful long­term 
surveillance and warning to patients regarding the risks of 
residual and recurrent disease, because several recent studies 
have reported recurrent invasive adenocarcinoma in patients 
with negative resection margins [7,14]. Therefore, clinicians 
should be aware that long­term follow­up is necessary for 
patients with cervical AIS after conization, regardless of the 
resection margin status. In the present study, the only patient 
who experienced recurrent AIS showed free resection margins 
after conization, and the recurrence was 47 months after the 
conization. 
Although LEEP is a good therapeutic method for young 
patients who wish to preserve their fertility, cold knife 
conization has been regarded as a more adequate therapeutic 
method for patients with cervical AIS. Many studies have 
shown that patients who underwent cold knife conization 
for the initial procedure are less likely to have positive 
margins than those who were treated with LEEP [12,14]. It 
was reported that cold knife conization produces a greater 
volume and depth of specimen [16,17] and the risk of 
recurrence was also decreased [12], and therefore, cold knife 
conization was recommended as the adequate method over 
other therapeutic modalities in the AIS of the uterine cervix. 
However in our study, comparison of conization methods 
was not possible because 90.9% of all patients underwent 
cold knife conization (Table 1). Our institution primarily 
treats patients with cervical AIS by cold knife conization for 
the initial surgery, which is based on previous studies which 
recommend cold knife conization as the best therapeutic 
modality for cervical AIS, and this resulted in 90 of 99 patients 
being treated by cold knife conization. In our institution, 
after cold knife conization, additional endocervical margin 
resection is done with a right triangle­shaped electrode, and 
then the bleeding site is cauterized with a round tip electrode. 
The reason for the low residual and recurrent AIS in our study 
is that this procedure removes residual AIS at the deep site of 
the endocervical area. However, some studies have observed 
that LEEP is technically easier and more rapid than cold 
knife conization [18]. Additionally, LEEP showed a favorable 
postoperative morbidity rate and a comparable success rate 
in some studies, and therefore, LEEP has been reported as 
a comparable treatment modality for cervical AIS [16,19]. In 
some reports, laser conization showed less or equivalent rates 
of negative margins over cold knife conization but larger 
volume of excision was possible than LEEP [13,20,21]. Further 
large prospective studies would make it possible to evaluate 
a more effective and safer therapeutic modality of AIS of the 
uterine cervix.
The infection rate of HPV 16 and 18 were noted as 43.9% 
and 22.8%, respectively, among 57 patients in whom the HPV 
testing was performed in our study. Bosch et al. [22] reported 
48.4% HPV 16 and 36.3% HPV 18 infection rates in their review 
article, and our results shows lower rates of HPV 16 and 18 
infections compared to the above data, especially with HPV 
18 infection. Some authors [23] have reported that AIS of the 
uterine cervix is more specific for HPV 18 infection, however, 
our study showed that rate of HPV 16 infection is higher 
than that of HPV 18 because patients with AIS coexisting 
squamous lesions is higher than those with AIS alone. The 
American Society for Colposcopy and Cervical Pathology 2006 
consensus guidelines recommend repeated evaluation using 
repeated cervical cytology, HPV DNA testing, and colposcopy 
with endocervical curettage [24]. The high risk HPV status 
before or after conization may be helpful to predict recurrence 
of AIS after conservative management. Further studies on HPV 
type distribution in cervical AIS in Korean population would Mi-La Kim, et al.
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be helpful for the better understanding of cervical AIS.
In conclusion, hysterectomy should be considered for 
patients with a diagnosis of AIS who do not want to preserve 
their fertility. However, patients with negative resection 
margins after conization for cervical AIS, especially who wish 
to preserve their fertility, may be followed carefully with long­
term surveillance and warning regarding the risks of residual 
or recurrent disease without hysterectomy. Patients with 
positive resection margins are more likely to have residual 
disease, so hysterectomy or a second conization to achieve 
negative margins may also be required. 
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